New drug indication approval - August 2021
|
Product Name
|
LIPIODOL ULTRA-FLUIDE INJECTION 38% W/W
|
|
Active Ingredient
|
Ethyl Esters of Iodised Fatty Acids of Poppy-Seed Oil
|
|
Product Registrant
|
ANGEION MEDICAL INTERNATIONAL PTE. LTD.
|
|
Date of Approval
|
26/08/2021
|
|
Indications:
Visualisation, locating and vectoring during transarterial chemoembolisation of intermediate-stage hepatocellular carcinoma in adults.
|
Healthcare professional, Industry member, Therapeutic Products
Published:
New Drug Indication Approvals